Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis

References

• Cully M. Cancer: tumour vessel normalization takes centre stage. Nat Rev Drug Discov. 2017 Feb 02;16(2):87. PubMed PMID: 28148936.
   Web of Science ®Google Scholar
• Park JS, Kim IK, Han S, et al. Normalization of tumor vessels by tie2 activation and ang2 inhibition enhances drug delivery and produces a favorable tumor microenvironment. Cancer Cell. 2017 Jan 09;31(1):157–20. PubMed PMID: 28073001.
   Web of Science ®Google Scholar
• Hendrix MJ, Seftor EA, Hess AR, et al. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer. 2003 Jun;3(6):411–421. PubMed PMID: 12778131; eng.
   PubMed Web of Science ®Google Scholar
• Wagenblast E, Soto M, Gutierrez-Angel S, et al. A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis. Nature. 2015 Apr 16;520(7547):358–362. PubMed PMID: 25855289; PubMed Central PMCID: PMCPMC4634366. eng.
   PubMed Web of Science ®Google Scholar
• Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science (New York, NY). 1999 Jun 18;284(5422):1994–1998. PubMed PMID: 10373119; eng.
   Google Scholar
• Kuczynski EA, Yin M, Bar-Zion A, et al. Co-option of liver vessels and not sprouting angiogenesis drives acquired sorafenib resistance in hepatocellular carcinoma. J Natl Cancer Inst. 2016 Aug;108(8). PubMed PMID: 27059374; PubMed Central PMCID: PMCPMC5017954. eng. DOI:10.1093/jnci/djw030
   Google Scholar
• Angara K, Borin TF, Arbab AS. Vascular mimicry: a novel neovascularization mechanism driving anti-angiogenic therapy (AAT) resistance in glioblastoma. Transl Oncol. 2017 Jun 29;10(4):650–660. PubMed PMID: 28668763; eng.
   Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015 Mar;65(2):87–108. PubMed PMID: 25651787.
   PubMed Web of Science ®Google Scholar
• Jayson GC, Kerbel R, Ellis LM, et al. Antiangiogenic therapy in oncology: current status and future directions. Lancet. 2016 Jul 30;388(10043):518–529. PubMed PMID: 26853587; eng.
   PubMed Web of Science ®Google Scholar
• Zhuang G, Wu X, Jiang Z, et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. Embo J. 2012 Aug 29;31(17):3513–3523. PubMed PMID: 22773185; PubMed Central PMCID: PMCPMC3433782. eng.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009 Jan 23;136(2):215–233. PubMed PMID: 19167326; PubMed Central PMCID: PMCPMC3794896. eng.
   PubMed Web of Science ®Google Scholar
• Drakaki A, Hatziapostolou M, Polytarchou C, et al. Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway. BMC Cancer. 2015 Jul 24;15:542. PubMed PMID: 26206264; PubMed Central PMCID: PMCPMC4512159.
   PubMed Web of Science ®Google Scholar
• Zhen Y, Xinghui Z, Chao W, et al. Several microRNAs could predict survival in patients with hepatitis B-related liver cancer. Sci Rep. 2017 Mar 21;7:45195. PubMed PMID: 28322348; PubMed Central PMCID: PMCPMC5359660. eng.
   Web of Science ®Google Scholar
• Ma L, Young J, Prabhala H, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol. 2010 Mar;12(3):247–256. PubMed PMID: 20173740; PubMed Central PMCID: PMCPMC2845545. eng.
   PubMed Web of Science ®Google Scholar
• Shojaei F, Wu X, Malik AK, et al. Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nat Biotechnol. 2007 Aug;25(8):911–920. PubMed PMID: 17664940; eng.
   PubMed Web of Science ®Google Scholar
• Zhang GY, Wang J, Jia YJ, et al. MicroRNA-9 promotes the neuronal differentiation of rat bone marrow mesenchymal stem cells by activating autophagy. Neural Regen Res. 2015 Feb;10(2):314–320. PubMed PMID: 25883633; PubMed Central PMCID: PMCPMC4392682. eng.
   Web of Science ®Google Scholar
• Mowers EE, Sharifi MN, Macleod KF. Functions of autophagy in the tumor microenvironment and cancer metastasis. Febs J. 2018 May;285(10):1751–1766. PubMed PMID: 29356327; PubMed Central PMCID: PMCPMC5992019. eng. .
   PubMed Web of Science ®Google Scholar
• Du J, Teng RJ, Guan T, et al. Role of autophagy in angiogenesis in aortic endothelial cells. Am J Physiol Cell Physiol. 2012 Jan 15;302(2):C383–91. PubMed PMID: 22031599; PubMed Central PMCID: PMCPMC3328843.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan S, Nguyen TM, Subramanian IV, et al. Autophagy and angiogenesis inhibition. Autophagy. 2007 Sep - Oct;3(5):512–515. PubMed PMID: 17643071; eng.
   Web of Science ®Google Scholar
• Todorova D, Simoncini S, Lacroix R, et al. Extracellular vesicles in angiogenesis. Circ Res. 2017 May 12;120(10):1658–1673. PubMed PMID: 28495996; PubMed Central PMCID: PMCPMC5426696. eng.
   PubMed Web of Science ®Google Scholar
• Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008 Dec;10(12):1470–1476. PubMed PMID: 19011622; PubMed Central PMCID: PMCPMC3423894.
   PubMed Web of Science ®Google Scholar
• Kamerkar S, LeBleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017 Jun 22;546(7659):498–503. PubMed PMID: 28607485; PubMed Central PMCID: PMCPMC5538883.
   PubMed Web of Science ®Google Scholar
• Treps L, Perret R, Edmond S, et al. Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles. J Extracell Vesicles. 2017;6(1):1359479. PubMed PMID: 28815003; PubMed Central PMCID: PMCPMC5549846. eng.
   PubMed Web of Science ®Google Scholar
• Hoshino A, Costa-Silva B, Shen TL, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015 Nov 19;527(7578):329–335. PubMed PMID: 26524530; PubMed Central PMCID: PMCPMC4788391. eng.
   PubMed Web of Science ®Google Scholar
• Amin MA, Campbell PL, Ruth JH, et al. A key role for Fut1-regulated angiogenesis and ICAM-1 expression in K/BxN arthritis. Ann Rheum Dis. 2015 Jul;74(7):1459–1466. PubMed PMID: 24665114; eng.
   Web of Science ®Google Scholar
• Jiang L, Lin L, Li R, et al. Dimer conformation of soluble PECAM-1, an endothelial marker. Int J Biochem Cell Biol. 2016 Aug;77(Pt A):102–108. PubMed PMID: 27270333; eng.
   Web of Science ®Google Scholar
• Schlingemann RO, Rietveld FJ, de Waal RM, et al. Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. Lab Invest. 1990 Jun;62(6):690–696. PubMed PMID: 1694254; eng.
   PubMed Web of Science ®Google Scholar
• Dan NZ, Khush KK, Romero LI, et al. CD34 is involved in endothelial cell apoptosis and angiogenesis. J Invest Dermatol. 1997;108(4):581.
   Web of Science ®Google Scholar
• Nguyen TM, Subramanian IV, Xiao X, et al. Endostatin induces autophagy in endothelial cells by modulating beclin 1 and beta-catenin levels. J Cell Mol Med. 2009 Sep;13(9b):3687–3698. PubMed PMID: 19298526; PubMed Central PMCID: PMCPMC4516517. eng.
   Web of Science ®Google Scholar
• Williams TF, Mirando AC, Wilkinson B, et al. Secreted threonyl-tRNA synthetase stimulates endothelial cell migration and angiogenesis. Sci Rep. 2013;3:1317. PubMed PMID: 23425968; PubMed Central PMCID: PMCPMC3578223.
   Web of Science ®Google Scholar
• Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004 Jul;84(3):869–901. PubMed PMID: 15269339; eng. .
   PubMed Web of Science ®Google Scholar
• Lotvall J, Hill AF, Hochberg F, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the international society for extracellular vesicles. J Extracell Vesicles. 2014;3:26913. PubMed PMID: 25536934; PubMed Central PMCID: PMCPMC4275645. eng.
   PubMedGoogle Scholar
• D’Souza-Schorey C, Clancy JW. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev. 2012 Jun 15;26(12):1287–1299. PubMed PMID: 22713869; PubMed Central PMCID: PMCPMC3387656. eng.
   PubMed Web of Science ®Google Scholar
• Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999 Sep;155(3):739–752. PubMed PMID: 10487832; PubMed Central PMCID: PMCPMC1866899. eng.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Adamis AP. Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discov. 2016 Jun;15(6):385–403. PubMed PMID: 26775688; eng. .
   PubMed Web of Science ®Google Scholar
• Hoeben A, Landuyt B, Highley MS, et al. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004 Dec;56(4):549–580. PubMed PMID: 15602010; eng.
   PubMed Web of Science ®Google Scholar
• Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004 Jun 3;350(23):2335–2342. PubMed PMID: 15175435.
   PubMed Web of Science ®Google Scholar
• Perren TJ, Swart AM, Pfisterer J, et al. A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med. 2011 Dec 29;365(26):2484–2496. PubMed PMID: 22204725; eng.
   PubMed Web of Science ®Google Scholar
• Hsu C, Yang TS, Huo TI, et al. Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study. J Hepatol. 2012 May;56(5):1097–1103. PubMed PMID: 22245891; eng.
   PubMed Web of Science ®Google Scholar
• Haas NB, Manola J, Uzzo RG, et al. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet. 2016 May 14;387(10032):2008–2016. PubMed PMID: 26969090; PubMed Central PMCID: PMCPMC4878938. eng.
   PubMed Web of Science ®Google Scholar
• Mitamura T, Gourley C, Sood AK. Prediction of anti-angiogenesis escape. Gynecol Oncol. 2016 Apr;141(1):80–85. PubMed PMID: 26748214; PubMed Central PMCID: PMCPMC4808422. eng. .
   Web of Science ®Google Scholar
• Bates DO, Hillman NJ, Williams B, et al. Regulation of microvascular permeability by vascular endothelial growth factors. J Anat. 2002 Jun;200(6):581–597. PubMed PMID: 12162726; PubMed Central PMCID: PMCPMC1570751. eng.
   PubMed Web of Science ®Google Scholar
• Shen S, Fan J, Cai B, et al. Vascular endothelial growth factor enhances cancer cell adhesion to microvascular endothelium in vivo. Exp Physiol. 2010 Feb;95(2):369–379. PubMed PMID: 19880535; PubMed Central PMCID: PMCPMC2859456. eng.
   Web of Science ®Google Scholar
• Peinado H, Zhang H, Matei IR, et al. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017 May;17(5):302–317. PubMed PMID: 28303905; eng.
   PubMed Web of Science ®Google Scholar
• Inoue K, Torimura T, Nakamura T, et al. Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice. Clin Cancer Res off J Am Assoc Cancer Res. 2012 Jul 15;18(14):3924–3933. 10.1158/1078-0432.ccr-11-2041. PubMed PMID: 22611027; eng.
   PubMed Web of Science ®Google Scholar
• Iwamoto H, Torimura T, Nakamura T, et al. Metronomic S-1 chemotherapy and vandetanib: an efficacious and nontoxic treatment for hepatocellular carcinoma. Neoplasia (New York, NY). 2011 Mar;13(3):187–197. PubMed PMID: 21390182; PubMed Central PMCID: PMCPMC3050862. eng.
   PubMed Web of Science ®Google Scholar
• Fan J, Fu BM. Quantification of malignant breast cancer cell MDA-MB-231 transmigration across brain and lung microvascular endothelium. Ann Biomed Eng. 2016 Jul;44(7):2189–2201. 10.1007/s10439-015-1517-y. PubMed PMID: 26603751; PubMed Central PMCID: PMCPMC4879597. eng.
   Web of Science ®Google Scholar
• Fu BM, Yang J, Cai B, et al. Reinforcing endothelial junctions prevents microvessel permeability increase and tumor cell adhesion in microvessels in vivo. Sci Rep. 2015 Oct 28;5:15697. PubMed PMID: 26507779; PubMed Central PMCID: PMCPMC4623601. eng.
   Web of Science ®Google Scholar
• Zhang L, Zeng M, Fu BM. Inhibition of endothelial nitric oxide synthase decreases breast cancer cell MDA-MB-231 adhesion to intact microvessels under physiological flows. Am J Physiol Heart Circ Physiol. 2016 Jun 1;310(11):H1735–47. PubMed PMID: 27059076; PubMed Central PMCID: PMCPMC4935524. eng.
   PubMed Web of Science ®Google Scholar
• Jain RK. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer Cell. 2014 Nov 10;26(5):605–622. PubMed PMID: 25517747; PubMed Central PMCID: PMCPMC4269830.
   PubMed Web of Science ®Google Scholar
• Sui X, Chen R, Wang Z, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 2013 Oct 10;4:e838. PubMed PMID: 24113172; PubMed Central PMCID: PMCPMC3824660. eng.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Meng X, Li C, et al. MiR-9 enhances the sensitivity of A549 cells to cisplatin by inhibiting autophagy. Biotechnol Lett. 2017 Jul;39(7):959–966. PubMed PMID: 28337557; eng.
   Web of Science ®Google Scholar
• Kang R, Zeh HJ, Lotze MT, et al. The beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011 Apr;18(4):571–580. PubMed PMID: 21311563; PubMed Central PMCID: PMCPMC3131912. eng.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ng S, Wang J, et al. Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways. Autophagy. 2015 Apr 3;11(4):629–642. PubMed PMID: 25919885; PubMed Central PMCID: PMCPMC4502718. eng.
   PubMed Web of Science ®Google Scholar
• Aishanjiang A, Rouzi N, Jiao Z, et al. MicroRNA-9 enhances invasion and migration of cervical carcinomas by directly targeting FOXO1. Eur Rev Med Pharmacol Sci. 2018 Apr;22(8):2253–2260. PubMed PMID: 29762826; eng.
   Web of Science ®Google Scholar
• Deng J, Lei W, Xiang X, et al. Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway. Oncotarget. 2016 Mar 1;7(9):10037–10050. PubMed PMID: 26840256; PubMed Central PMCID: PMCPMC4891102. eng.
   Google Scholar
• Wilkinson DS, Jariwala JS, Anderson E, et al. Phosphorylation of LC3 by the Hippo kinases STK3/STK4 is essential for autophagy. Mol Cell. 2015 Jan 8;57(1):55–68. PubMed PMID: 25544559; PubMed Central PMCID: PMCPMC4373083. eng.
   PubMed Web of Science ®Google Scholar
• Li X, He L, Yue Q, et al. MiR-9-5p promotes MSC migration by activating beta-catenin signaling pathway. Am J Physiol Cell Physiol. 2017 Jul 1;313(1):C80–c93. PubMed PMID: 28424168; eng.
   Web of Science ®Google Scholar
• Turcios L, Chacon E, Garcia C, et al. Autophagic flux modulation by Wnt/beta-catenin pathway inhibition in hepatocellular carcinoma. PloS One. 2019;14(2):e0212538. PubMed PMID: 30794613; PubMed Central PMCID: PMCPMC6386480. eng.
   Web of Science ®Google Scholar
• Roese-Koerner B, Stappert L, Brustle O. Notch/Hes signaling and miR-9 engage in complex feedback interactions controlling neural progenitor cell proliferation and differentiation. Neurogenesis (Austin, Tex). 2017;4(1):e1313647. PubMed PMID: 28573150; PubMed Central PMCID: PMCPMC5443189. eng.
   PubMedGoogle Scholar
• Wu X, Fleming A, Ricketts T, et al. Autophagy regulates notch degradation and modulates stem cell development and neurogenesis. Nat Commun. 2016 Feb 3;7:10533. PubMed PMID: 26837467; PubMed Central PMCID: PMCPMC4742842. eng.
   PubMed Web of Science ®Google Scholar
• Zheng L, Qi T, Yang D, et al. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1. PloS One. 2013;8(1):e55719. PubMed PMID: 23383271; PubMed Central PMCID: PMCPMC3561302. eng.
   PubMed Web of Science ®Google Scholar
• Casimiro MC, Di Sante G, Di Rocco A, et al. Cyclin D1 restrains oncogene-induced autophagy by regulating the AMPK-LKB1 signaling axis. Cancer Res. 2017 Jul 1;77(13):3391–3405. PubMed PMID: 28522753; PubMed Central PMCID: PMCPMC5705201. eng.
   PubMed Web of Science ®Google Scholar
• Yang L, Chao J, Kook YH, et al. Involvement of miR-9/MCPIP1 axis in PDGF-BB-mediated neurogenesis in neuronal progenitor cells. Cell Death Dis. 2013 Dec 12;4:e960. PubMed PMID: 24336080; PubMed Central PMCID: PMCPMC3877557. eng.
   Web of Science ®Google Scholar
• Ricci-Vitiani L, Pallini R, Biffoni M, et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature. 2010 Dec 9;468(7325):824–828. PubMed PMID: 21102434; eng.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Zou J, et al. Tetrahydrocurcumin induces mesenchymal-epithelial transition and suppresses angiogenesis by targeting HIF-1alpha and autophagy in human osteosarcoma. Oncotarget. 2017 Oct 31;8(53):91134–91149. PubMed PMID: 29207631; PubMed Central PMCID: PMCPMC5710911. eng.
   Google Scholar
• Wu HB, Yang S, Weng HY, et al. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells. Autophagy. 2017 Sep 2;13(9):1528–1542. PubMed PMID: 28812437; PubMed Central PMCID: PMCPMC5612353. eng.
   PubMed Web of Science ®Google Scholar
• Soda Y, Myskiw C, Rommel A, et al. Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme. J Mol Med (Berl). 2013 Apr;91(4):439–448. PubMed PMID: 23512266; PubMed Central PMCID: PMCPMC3665343. eng.
   Web of Science ®Google Scholar
• Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002 Aug;2(8):569–579. PubMed PMID: 12154376; eng. .
   PubMed Web of Science ®Google Scholar
• Fader CM, Colombo MI. Multivesicular bodies and autophagy in erythrocyte maturation. Autophagy. 2006 Apr - Jun;2(2):122–125. PubMed PMID: 16874060; eng.
   PubMed Web of Science ®Google Scholar
• Fader CM, Sanchez D, Furlan M, et al. Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells. Traffic. 2008 Feb;9(2):230–250. PubMed PMID: 17999726; eng.
   PubMed Web of Science ®Google Scholar
• Minakaki G, Menges S, Kittel A, et al. Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy. 2017 Dec 4:1–61. PubMed PMID: 29198173; eng. DOI: 10.1080/15548627.2017.1395992
   Web of Science ®Google Scholar
• Liu JX, Yan ZP, Zhang YY, et al. Hemodynamic shear stress regulates the transcriptional expression of heparan sulfate proteoglycans in human umbilical vein endothelial cell. Cell Mol Biol (Noisy-Le-Grand). 2016;62(8):28–34. PubMed PMID: 27545211.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Liu J. Role of glypican-1 in endothelial NOS activation under various steady shear stress magnitudes. Exp Cell Res. 2016 Nov 01;348(2):184–189. PubMed PMID: 27688027.
   PubMed Web of Science ®Google Scholar
• Ponce ML. Tube formation: an in vitro matrigel angiogenesis assay. Methods Mol Biol. 2009;467:183–188. PubMed PMID: 19301671.
   PubMedGoogle Scholar
• Malinda KM. In vivo matrigel migration and angiogenesis assay. Methods Mol Biol. 2009;467:287–294. PubMed PMID: 19301678.
   PubMedGoogle Scholar
• Zeng Y, Yao X, Chen L, et al. Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/syndecan-1/TGF-beta autocrine loop. Oncotarget. 2016 Sep 27;7(39):63324–63337. PubMed PMID: 27556509.
   PubMedGoogle Scholar
• Zeng Y, Adamson RH, Curry FR, et al. Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding. Am J Physiol Heart Circ Physiol. 2014 Feb;306(3):H363–72. PubMed PMID: 24285115; PubMed Central PMCID: PMCPMC3920139.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Ebong EE, Fu BM, et al. The structural stability of the endothelial glycocalyx after enzymatic removal of glycosaminoglycans. PloS One. 2012;7(8):e43168. PubMed PMID: 22905223; PubMed Central PMCID: PMCPMC3419189. eng.
   PubMed Web of Science ®Google Scholar